Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.
Open Access
- 1 June 1995
- Vol. 50 (6) , 645-650
- https://doi.org/10.1136/thx.50.6.645
Abstract
BACKGROUND--The neutrophil elastase inhibitor, secretory leucocyte protease inhibitor (SLPI), is a potential therapeutic tool in inflammatory lung diseases such as cystic fibrosis and pulmonary emphysema. The distribution and disappearance in the lung of aerosolised recombinant SLPI (rSLPI) was investigated in healthy humans and in patients with cystic fibrosis or alpha 1-antitrypsin-associated emphysema. METHODS--To distinguish aerosolised rSLPI from endogenous SLPI the recombinant inhibitor was radiolabelled with 99m-technetium (99mTc) pertechnetate. Distribution and disappearance of aerosolised 99mTc-rSLPI in the lungs were studied by gamma radiation imaging. RESULTS--The deposition of 99mTc-rSLPI in normal volunteers was homogeneous in all lung lobes, while in patients with cystic fibrosis or emphysema only well ventilated areas showed deposition of the aerosol. The disappearance rate of 99mTc-rSLPI was biexponential. The half life of the rapid phase was 0.2-2.8 hours, while that of the slow phase was more than 24 hours. CONCLUSIONS--Future aerosol therapy with rSLPI will be most beneficial for well ventilated lung tissue that needs protection against neutrophil derived elastase. It may be more difficult to neutralise the burden of elastase in poorly ventilated, highly inflamed areas as are seen in cystic fibrosis.Keywords
This publication has 23 references indexed in Scilit:
- The labeling of proteins and LDL with 99mTc: a new direct method employing KBH4 and stannous chlorideNuclear Medicine and Biology, 1993
- Pharmacokinetics of Recombinant Secretory Leukoprotease Inhibitor Aerosolized to Normals and Individuals with Cystic FibrosisAmerican Review of Respiratory Disease, 1993
- Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.Journal of Clinical Investigation, 1990
- Pharmacokinetics and Distribution of Recombinant Secretory Leukocyte Proteinase Inhibitor in RatsAmerican Review of Respiratory Disease, 1990
- Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domainBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.Journal of Clinical Investigation, 1990
- Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.Journal of Clinical Investigation, 1989
- Antileukoprotease Is Associated with Elastin Fibers in the Extracellular Matrix of the Human Lung: An Immunoelectron Microscopic StudyAmerican Review of Respiratory Disease, 1989
- Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase.Proceedings of the National Academy of Sciences, 1986
- Antileukoprotease in Sputum during Bronchial InfectionsChest, 1986